S100P contributes to promoter demethylation and transcriptional activation of SLC2A5 to promote metastasis in colorectal cancer
-
Published:2021-06-29
Issue:5
Volume:125
Page:734-747
-
ISSN:0007-0920
-
Container-title:British Journal of Cancer
-
language:en
-
Short-container-title:Br J Cancer
Author:
Lin MingdaoORCID, Fang Yuan, Li Zhenkang, Li Yongsheng, Feng Xiaochuang, Zhan Yizhi, Xie Yuwen, Liu Yuechen, Liu Zehao, Li GuoxinORCID, Shen ZhiyongORCID, Deng HaijunORCID
Abstract
Abstract
Background
SLC2A5 is a high-affinity fructose transporter, which is frequently upregulated in multiple human malignant tumours. However, the function and molecular mechanism of SLC2A5 in colorectal cancer (CRC) remain unknown.
Methods
We detected the expression levels of SLC2A5 in CRC tissues and CRC cell lines by western blotting, qRT-PCR and immunohistochemistry. CRC cell lines with stable overexpression or knockdown of SLC2A5 were constructed to evaluate the functional roles of SLC2A5 in vitro through conventional assays. An intrasplenic inoculation model was established in mice to investigate the effect of SLC2A5 in promoting metastasis in vivo. Methylation mass spectrometry sequencing, methylation specific PCR, bisulphite sequencing PCR, ChIP-qPCR and luciferase reporter assay were performed to investigate the molecular mechanism underlying transcriptional activation of SLC2A5.
Results
We found that SLC2A5 was upregulated in colorectal tumour tissues. Functionally, a high level of SLC2A5 expression was associated with increased invasion and metastasis capacities of CRC cells both in vitro and in vivo. Mechanistically, we unveiled that S100P could integrate to a specific region of SLC2A5 promoter, thereby reducing its methylation levels and activating SLC2A5 transcription.
Conclusions
Our results reveal a novel mechanism that S100P mediates the promoter demethylation and transcription activation of SLC2A5, thereby promoting the metastasis of CRC.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Reference63 articles.
1. Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A. & Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394–424 (2018). 2. Brenner, H., Kloor, M. & Pox, C. P. Colorectal cancer. Lancet 383, 1490–1502 (2014). 3. Deng, F., Zhou, R., Lin, C., Yang, S., Wang, H., Li, W. et al. Tumor-secreted dickkopf2 accelerates aerobic glycolysis and promotes angiogenesis in colorectal cancer. Theranostics 9, 1001–1014 (2019). 4. Jiao, H. L., Ye, Y. P., Yang, R. W., Sun, H. Y., Wang, S. Y., Wang, Y. X. et al. Downregulation of SAFB sustains the NF-kappaB pathway by targeting TAK1 during the progression of colorectal cancer. Clin. Cancer Res. 23, 7108–7118 (2017). 5. Prica, F., Radon, T., Cheng, Y. & Crnogorac-Jurcevic, T. The life and works of S100P—from conception to cancer. Am. J. Cancer Res. 6, 562–576 (2016).
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|